JANE STREET GROUP, LLC

Position in ACET — Adicet Bio, Inc.

CIK 1595888 NEW YORK, NY

Position in ACET

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$609,646

+$357,105 QoQ

Shares Held

70,561

+90.3% QoQ

Ownership

0.754%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#20

of 56 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,363,996,810 across 291 Biotechnology names. ACET ranks #106 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	2,934,193	$218,538,693
2	MDGL	Madrigal Pharmaceuticals, Inc.	191,541	$102,847,939
3	AXSM	Axsome Therapeutics, Inc.	403,995	$98,885,855
4	TGTX	Tg Therapeutics, Inc.	1,752,646	$96,290,370
5	EXEL	Exelixis, Inc.	1,402,438	$76,306,651
6	QURE	uniQure N.V.	1,610,483	$74,178,846
7	HALO	Halozyme Therapeutics, Inc.	694,684	$54,372,915
8	TVTX	Travere Therapeutics, Inc.	938,699	$53,327,489

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$609,646	70,561	+90.3%	Shares	Defined	2026-08-14
2026-03-31	$252,541	37,084	-80.1%	Shares	Defined	2026-05-12
2025-09-30	$150,822	186,200	+1412.3%	Shares	Defined	2025-11-14
2024-12-31	$11,843	12,312	-83.5%	Shares	Defined	2025-02-14
2024-09-30	$107,664	74,767	-63.9%	Shares	Defined	2024-11-15
2024-06-30	$250,512	207,036	+253.4%	Shares	Defined	2024-08-15
2024-03-31	$137,686	58,590	+154.6%	Shares	Defined	2024-05-16
2023-12-31	$43,492	23,012	-85.3%	Shares	Defined	2024-02-15
2023-03-31	$903,357	156,833	+833.3%	Shares	Defined	2023-05-16
2022-12-31	$150,227	16,804	-92.1%	Shares	Defined	2023-02-15
2022-09-30	$3,020,384	212,404	+1067.1%	Shares	Defined	2022-11-15
2021-03-31	$238,056	18,200	—	Shares	Defined	2021-05-18
No filing history on record for this holder in this stock.